LOS ANGELES, CA -- (Marketwired) -- 11/06/13 -- In case you haven-t already heard, over in…
Continue ReadingTag: biomedreports
Once-a-Week Insulin Shot Could Help Growing Diabetes Patient Base and Spell Huge Profits for Investors
LOS ANGELES, CA -- (Marketwire) -- 02/22/13 -- In January 2013, newly trading AntriaBio, Inc. (OTCQB:…
Continue ReadingCyclacel Pharmaceuticals Looks Undervalued Given Potential Frontline Leukemia Drug
LOS ANGELES, CA -- (Marketwire) -- 02/21/13 -- is a development-stage biopharmaceutical company dedicated to the…
Continue ReadingPozen: An Undervalued Investment and Catalyst Trade Opportunity
LOS ANGELES, CA -- (Marketwire) -- 02/11/13 -- Small cap biopharmas that make for good long…
Continue ReadingUnder Appreciated Tekmira Starting to Bounce May Head Higher as Sector Heats Up
LOS ANGELES, CA -- (Marketwire) -- 01/31/13 -- Immediately after Tekmira (NASDAQ: TKMR) (TSX: TKM) announced…
Continue ReadingNovel Alzheimer-s Therapeutics Developer Says Investors Should Remain Undeterred Despite Disappointing Results From Major Phase 3 Trials
LOS ANGELES, CA -- (Marketwire) -- 01/30/13 -- During his distinguished career, Dr. Daniel G. Chain,…
Continue ReadingCelsion — A Simple Model to Determine Fair Value
LOS ANGELES, CA -- (Marketwire) -- 01/29/13 -- Investors in Celsion Corporation are eagerly awaiting the…
Continue ReadingIs MMR Global-s Personal Health Records Patent Portfolio Worth a Closer Look?
LOS ANGELES, CA -- (Marketwire) -- 01/23/13 -- The Michael Bass Group, an investment banking and…
Continue ReadingAnticipating Neptune-s Big Bounce to Continue
LOS ANGELES, CA -- (Marketwire) -- 01/15/13 -- Neptune Technologies & Bioresources (NASDAQ: NEPT) a conference…
Continue ReadingNear Term Catalyst Has ArQule Poised for a Move Up
LOS ANGELES, CA -- (Marketwire) -- 12/18/12 -- ArQule, Inc. engages in the research and development…
Continue Reading